Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Fesoterodine

Criteria

Inclusion Criteria:

• Over-active bladder

• Prescribed with Fesoterodine

Exclusion Criteria:

• Hypersensitivity

• Urinary retention